Effect of inhaled corticosteroids on forearm bone mineral density: The HUNT Study, Norway

Respiratory Medicine

Volumn 101, Issue 8, 2007, Pages 1744-1752

  Langhammer, Arnulf ^a   Forsmo, Siri ^a   Lilleeng, Solfrid ^a   Johnsen, Roar ^a   Bjermer, Leif ^b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Asthma; Bone densitometry (SXA); COPD; Corticosteroid osteoporosis; Inhaled corticosteroids

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; ESTROGEN; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL;

ADULT; AGED; ARTICLE; ASTHMA; BONE DENSITOMETRY; BONE DENSITY; BONE DISEASE; BONE MINERAL; CAUSAL ATTRIBUTION; CHRONIC BRONCHITIS; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EXPOSURE; DRUG USE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FOREARM; HORMONE SUBSTITUTION; HUMAN; INTERVIEW; LONGITUDINAL STUDY; LOW DRUG DOSE; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; NORWAY; OBSERVATIONAL STUDY; OSTEOLYSIS; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RISK FACTOR; SEX DIFFERENCE; SIDE EFFECT; SPIROMETRY; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; AGED; ASTHMA; BONE DENSITY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; FOREARM; HUMANS; MALE; MIDDLE AGED; NORWAY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 34250712388     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.02.018     Document Type: Article

References (32)

1. Global Initiatives for Asthma. Global Strategy for asthma management and prevention NHLBI/WHO workshop. National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD (US-DHHS/PHS/NIH Publication No.02-3659), 2002 April.
2. Pauwels R.A., Buist A.S., Ma P., Jenkins C.R., and Hurd S.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care 46 8 (2001) 798-825
3. Van Staa T.P., Leufkens H.G., and Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13 10 (2002) 777-787
4. Suissa S., Baltzan M., Kremer R., and Ernst P. Inhaled and nasal corticosteroid use and the risk of fracture. Am J Respir Crit Care Med 169 1 (2004) 83-88
5. Hubbard R.B., Smith C.J., Smeeth L., Harrison T.W., and Tattersfield A.E. Inhaled corticosteroids and hip fracture: a population-based case-control study. Am J Respir Crit Care Med 166 12, Part 1 (2002) 1563-1566
6. Leone F.T., Fish J.E., Szefler S.J., and West S.L. Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology. Chest 124 6 (2003) 2329-2340
7. Lane N.E., and Lukert B. The science and therapy of glucocorticoid-induced bone loss. Endocrinol Metab Clin North Am 27 2 (1998) 465-483
8. Marshall D., Johnell O., and Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures [see comments]. BMJ 312 7041 (1996) 1254-1259
9. Langhammer A., Johnsen R., Holmen J., Gulsvik A., and Bjermer L. Cigarette smoking gives more respiratory symptoms among women than among men. J Epidemiol Community Health 54 12 (2000) 917-922
10. Langhammer A., Norjavaara E., de Verdier M.G., Johnsen R., and Bjermer L. Use of inhaled corticosteroids and bone mineral density in a population based study: the Nord-Trondelag Health Study (the HUNT Study). Pharmacoepidemiol Drug Saf 13 8 (2004) 569-579
11. Langhammer A., Johnsen R., Gulsvik A., Holmen T.L., and Bjermer L. Forced spirometry reference values for Norwegian adults: the bronchial obstruction in Nord-Trondelag Study. Eur Respir J (JID-8803460) 18 5 (2001) 770-779
12. Dubois E.F. Clinical potencies of glucocorticoids: what do we really measure?. Curr Respir Med Rev 1 (2005) 103-108
13. Cummings S.R., Bates D., and Black D.M. Clinical use of bone densitometry: scientific review. JAMA 288 15 (2002) 1889-1897
14. Melton L.J., Atkinson E.J., O'Connor M.K., O'Fallon W.M., and Riggs B.L. Bone density and fracture risk in men. J Bone Miner Res 13 12 (1998) 1915-1923
15. Hassager C., Jensen S., Gotfredsen A., and Christiansen C. The impact of measurement errors on the diagnostic value of bone mass measurements: theoretical considerations. Osteoporosis Int 1 (1991) 250-256
16. Rosvold Berntsen G.K., Fonnebo V., Tollan A., Sogaard A.J., Joakimsen R.M., and Magnus J.H. The Tromso Study: determinants of precision in bone densitometry. J Clin Epidemiol 53 11 (2000) 1104-1112
17. Augat P., Fuerst T., and Genant H.K. Quantitative bone mineral assessment at the forearm: a review. Osteoporos Int 8 4 (1998) 299-310
18. Tashkin D.P., Murray H.E., Skeans M., and Murray R.P. Skin manifestations of inhaled corticosteroids in COPD patients: results from Lung Health Study II. Chest 126 4 (2004) 1123-1133
19. Van Staa T.P., Leufkens H.G., Abenhaim L., Zhang B., and Cooper C. Use of oral corticosteroids and risk of fractures [see comments]. J Bone Miner Res 15 6 (2000) 993-1000
20. Tattersfield A.E., Town G.I., Johnell O., Picado C., Aubier M., Braillon P., et al. Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years. Thorax 56 4 (2001) 272-278
21. Gan W.Q., Man S.F., Senthilselvan A., and Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59 7 (2004) 574-580
22. Jones A., Fay J.K., Burr M., Stone M., Hood K., and Roberts G. Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease (Cochrane Review). Cochrane Database Syst Rev (JID-100909747) 1 (2002) CD003537
23. Wong C.A., Walsh L.J., Smith C.J., Wisniewski A.F., Lewis S.A., Hubbard R., et al. Inhaled corticosteroid use and bone-mineral density in patients with asthma [see comments]. Lancet 355 9213 (2000) 1399-1403
24. Elmstahl S., Ekstrom H., Galvard H., Johnell O., Gerhardsson d.V., and Norjavaara E. Is there an association between inhaled corticosteroids and bone density in postmenopausal women?. J Allergy Clin Immunol 111 1 (2003) 91-96
25. Richy F., Bousquet J., Ehrlich G.E., Meunier P.J., Israel E., Morii H., et al. Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review. Osteoporos Int 14 3 (2003) 179-190
26. Israel E., Banerjee T.R., Fitzmaurice G.M., Kotlov T.V., LaHive K., and Leboff M.S. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med 345 13 (2001) 941-947
27. Halpern M.T., Schmier J.K., Van K., Watkins M., and Kalberg C.J. Impact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysis. Ann Allergy Asthma Immunol 92 2 (2004) 201-207
28. Sharma P.K., Malhotra S., Pandhi P., and Kumar N. Effect of inhaled steroids on bone mineral density: a meta-analysis. J Clin Pharmacol 43 2 (2003) 193-197
29. Martin R.J., Szefler S.J., Chinchilli V.M., Kraft M., Dolovich M., Boushey H.A., et al. Systemic effect comparisons of six inhaled corticosteroid preparations. Am J Respir Crit Care Med 165 10 (2002) 1377-1383
30. Van Staa T.P., Leufkens H.G., and Cooper C. Use of inhaled corticosteroids and risk of fractures. J Bone Miner Res (JID-8610640) 16 3 (2001) 581-588
31. Vestergaard P., Rejnmark L., and Mosekilde L. Fracture risk associated with systemic and topical corticosteroids. J Intern Med 257 4 (2005) 374-384
32. Kanis J.A., Johansson H., Oden A., Johnell O., de L.C., Melton III L.J., et al. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19 6 (2004) 893-899